Saint Luke's Mid America Heart Institute and the University of Missouri, Kansas City, Missouri 64111, USA.
JACC Cardiovasc Interv. 2012 Feb;5(2):229-35. doi: 10.1016/j.jcin.2011.12.004. Epub 2012 Feb 8.
Appropriate utilization of percutaneous coronary intervention (PCI) and medical therapy is deservedly a national healthcare policy priority for the United States. Because PCI is both common and costly, appraisal of appropriateness is warranted. The initial appropriate use criteria (AUC) have been developed for coronary revascularization procedures and investigators recently reported the appropriateness for the approximately 500,000 PCI procedures performed at centers participating in the National Cardiovascular Data Registry. The AUC have broad implications for both healthcare providers and our patients and will be used as the basis for indications, referral patterns, treatment options, physician education, shared decision-making, and reimbursement for years to come. While we acknowledge the importance of thoughtfully assessing appropriateness for all medical procedures including PCI, there are a number of concerns with the current AUC and methods used to report appropriateness that warrant expanded commentary.
经皮冠状动脉介入治疗(PCI)和药物治疗的合理应用理应成为美国国家医疗保健政策的重点。鉴于 PCI 既常见又昂贵,因此有必要对其进行适当性评估。目前已经制定了冠状动脉血运重建手术的初始适当使用标准(AUC),并且研究人员最近报告了在参与国家心血管数据注册中心的中心进行的大约 50 万例 PCI 手术的适当性。AUC 对医疗保健提供者和我们的患者都具有广泛的影响,并将作为未来多年的适应症、转诊模式、治疗选择、医生教育、共同决策和报销的基础。虽然我们认识到认真评估包括 PCI 在内的所有医疗程序的适当性的重要性,但目前 AUC 以及用于报告适当性的方法存在一些需要进一步讨论的问题。